BMY vs CARR · P/E 17, rev $24.46B vs P/E 43, rev $21.75B
Bristol-Myers Squibb Company (BMY) versus Carrier Global Corp (CARR) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Carrier Global Corp (CARR) is a building products & equipment company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported CARR revenue for 2025-12-31 was $21.75B. Net income was $1.48B. Revenue was up 322.4% from 2024-12-31 to 2025-12-31. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
Not investment advice. Open the BMY and CARR stock pages for the full models.
Not investment advice.